FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 321:947-952 October 5, 1989 Number 14 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Patients infected by the human immunodeficiency virus (HIV) as a result of blood transfusions are unique in that their dates of infection are well defined and their medical conditions before infection are known. To characterize the natural history of transfusion-associated HIV infection, we studied 694 recipients of blood from 112 donors in whom AIDS later developed and from 31 donors later found to be positive for HIV antibody. Of the recipients tested, 85 were seronegative, 116 were seropositive, and 19 had AIDS. Of 101 HIV-seropositive recipients followed for a median of 55 months after infection, 54 had Centers for Disease Control Class IV disease, including 43 with AIDS. Life-table analysis suggested that AIDS will develop in 49 percent of infected recipients (95 percent confidence limits, 36 to 62 percent) within seven years after infection. As compared with recipients without AIDS, the 43 recipients with AIDS had received more transfusions at the time of infection (median, 21 vs. 7; P = 0.01). HIV-infected blood donors in whom AIDS developed were grouped according to whether AIDS developed within 29 months (the median) after donation (Group 1) or 29 or more months after donation (Group 2). As compared with the 31 recipients of blood from Group 2 blood donors, the 31 recipients of blood from Group 1 donors were more likely to have AIDS four years after infection (49 percent vs. 4 percent; P = 0.005) and illnesses resembling acute retroviral syndrome (14 of 24 vs. 5 of 22; P = 0.03). We conclude that most recipients of HIV-infected blood become seropositive, that AIDS develops in about half these recipients within seven years, and that the risk may be higher when AIDS develops in the blood donor soon after donation.

Source Information

AIDS Program, Center for Disease Control, Atlanta, GA 30333.

This article has been cited by other articles:

• Krahn, M., Wong, J. B., Heathcote, J., Scully, L., Seeff, L. (2004). Estimating the Prognosis of Hepatitis C Patients Infected by Transfusion in Canada between 1986 and 1990. Med Decis Making 24: 20-29 [Abstract]  
• Katzenstein, T. L., Dickmeiss, E., Aladdin, H., Hede, A., Nielsen, C., Nielsen, H., Jorgensen, L. B., Gerstoft, J. (2000). Failure To Develop HIV Infection after Receipt of HIV-Contaminated Blood and Postexposure Prophylaxis. ANN INTERN MED 133: 31-34 [Abstract] [Full Text]  
• Makadon, H. J. (1999). An Asymptomatic 41-Year-Old Man With HIV Infection. JAMA 281: 739-744 [Full Text]  
• Stranford, S. A., Skurnick, J., Louria, D., Osmond, D., Chang, S.-Y., Sninsky, J., Ferrari, G., Weinhold, K., Lindquist, C., Levy, J. A. (1999). Lack of infection in HIV-exposed individuals is associated with a strong CD8+ cell noncytotoxic anti-HIV response. Proc. Natl. Acad. Sci. USA 96: 1030-1035 [Abstract] [Full Text]  
• Franceschi, S, Maso, L D., La Vecchia, C (1995). Trends in incidence of AIDS associated with transfusion of blood and blood products in Europe and the United States, 1985-93. BMJ 311: 1534-1536 [Abstract] [Full Text]  
• Deacon, N. J., Tsykin, A., Solomon, A., Smith, K., Ludford-Menting, M., Ellett, A., Hooker, D. J., McPhee, D. A., Greenway, A. L., Chatfield, C., Lawson, V. A., Crowe, S., Maerz, A., Sonza, S., Learmont, J., Sullivan, J. S., Cunningham, A., Dwyer, D., Dowton, D., Mills, J. (1995). Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients. Science 270: 988-991 [Abstract]  
• Remafedi, G., Lauer, T. (1995). Survival Trends in Adolescents With Human Immunodeficiency Virus Infection. Arch Pediatr Adolesc Med 149: 1093-1096 [Abstract]  
• King, S. M., Murphy, T., Corey, M., Newman, A. M., Major, C., McCrindle, B. W., Irwin, J., Stevens, M., Fearon, M., Poon, A. O. (1995). The HIV Information Project for Transfusion Recipients a Decade After Transfusion. Arch Pediatr Adolesc Med 149: 680-685 [Abstract]  
• Etchason, J., Petz, L., Keeler, E., Calhoun, L., Kleinman, S., Snider, C., Fink, A., Brook, R. (1995). The Cost Effectiveness of Preoperative Autologous Blood Donations. NEJM 332: 719-724 [Abstract] [Full Text]  
• Araneta, M. R. G., Mascola, L., Eller, A., O'Neil, L., Ginsberg, M. M., Bursaw, M., Marik, J., Friedman, S., Sims, C. A., Rekart, M. L., Collie, F. (1995). HIV Transmission Through Donor Artificial Insemination. JAMA 273: 854-858 [Abstract]  
• Rutherford, G W (1994). Long term survival in HIV-1 infection. BMJ 309: 283-284 [Full Text]  
• Blanche, S., Mayaux, M.-J., Rouzioux, C., Teglas, J.-P., Firtion, G., Monpoux, F., Cicaru-Vigneron, N., Meier, F., Tricoire, J., Courpotin, C., Vilmer, E., Griscelli, C., Delfraissy, J.-F., The French Pediatric HIV Infection Study Group, (1994). Relation of the Course of HIV Infection in Children to the Severity of the Disease in Their Mothers at Delivery. NEJM 330: 308-312 [Abstract] [Full Text]  
• Mintz, P. D. (1993). Participation of HIV-Infected Patients in Autologous Blood Programs. JAMA 269: 2892-2894 [Abstract]  
• Henry, D. H., Beall, G. N., Benson, C. A., Carey, J., Cone, L. A., Eron, L. J., Fiala, M., Fischl, M. A., Gabin, S. J., Gottlieb, M. S., Galpin, J. E., Groopman, J. E., Hooton, T. M., Jemsek, J. G., Levine, R. L., Miles, S. A., Rinehart, J. J., Rios, A., Robbins, W. J., Ruckdeschel, J. C., Smith, J. A., Spruance, S. L., Starrett, B., Toney, J., Zalusky, R., Abels, R. I., Bryant, E. C., Larholt, K. M., Sampson, A. R., Rudnick, S. A. (1992). Recombinant Human Erythropoietin in the Treatment of Anemia Associated with Human Immunodeficiency Virus (HIV) Infection and Zidovudine Therapy: Overview of Four Clinical Trials. ANN INTERN MED 117: 739-748 [Abstract]  
• Schulman, K. A., Lynn, L. A., Glick, H. A., Eisenberg, J. M. (1991). Cost Effectiveness of Low-Dose Zidovudine Therapy for Asymptomatic Patients with Human Immunodeficiency Virus (HIV) Infection. ANN INTERN MED 114: 798-802 [Abstract]  
• (1990). Possible Transmission of Human Immunodeficiency Virus to a Patient During an Invasive Dental Procedure. Arch Dermatol 126: 1553-1555 [Abstract]  
• Klein, R. S., Friedland, G. H. (1990). Transmission of Human Immunodeficiency Virus Type 1 (HIV-1) by Exposure to Blood: Defining the Risk. ANN INTERN MED 113: 729-730 [Abstract]  
• Donegan, E., Stuart, M., Niland, J. C., Sacks, H. S., Azen, S. P., Dietrich, S. L., Faucett, C., Fletcher, M. A., Kleinman, S. H., Operskalski, E. A., Perkins, H. A., Pindyck, J., Schiff, E. R., Stites, D. P., Tomasulo, P. A., Mosley, J. W., Transfusion Safety Group, (1990). Infection with Human Immunodeficiency Virus Type 1 (HIV-1) among Recipients of Antibody-Positive Blood Donations. ANN INTERN MED 113: 733-739 [Abstract]  
• (1990). Possible Transmission of Human Immunodeficiency Virus to a Patient During an Invasive Dental Procedure. JAMA 264: 1092-1093  
• Nelson, K. E., Vlahov, D., Margolick, J., Bernal, M., Taylor, E. (1990). Blood and Plasma Donations Among a Cohort of Intravenous Drug Users. JAMA 263: 2194-2197 [Abstract]  
• Cohen, D. G. (1990). Similarities Between the Nursing Care Needs of Children with Cancer and Children With Human Immunodeficiency Virus Infection. Journal of Pediatric Oncology Nursing 7: 149-153 [Abstract]  
• (1989). HIV INFECTION VIA TRANSFUSION IS RARE, BUT OUTCOME IS DIRE. JWatch General 1989: 2-2 [Full Text]